Sun Pharma#39;s offer amounts to about $347.8 million, as per Reuters calculations, with the per share value at a 4.2% premium to Taro#39;s close on Wednesday.from Moneycontrol Business News https://ift.tt/ilmVqGQ
via IFTTT
Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 million
January 17, 2024
0
Sun Pharma#39;s offer amounts to about $347.8 million, as per Reuters calculations, with the per share value at a 4.2% premium to Taro#39;s close on Wednesday.from Moneycontrol Business News https://ift.tt/ilmVqGQ
via IFTTT
